(MLHK) H&K - Ratings and Ratios
Pistols,Rifles,Submachine,Guns,Training
MLHK EPS (Earnings per Share)
MLHK Revenue
Description: MLHK H&K
Heckler & Koch AG (MLHK) is a German aerospace and defense company, operating in the GICS sub-industry of Aerospace & Defense. The companys stock is a common stock listed on a German exchange.
To evaluate the investment potential of MLHK, we need to analyze its financial performance. The Income Tax Expense is a crucial component of the companys income statement, influencing its net income. A thorough examination of this expense can reveal insights into the companys tax strategy and its impact on profitability.
With a Market Cap of 2625.73M EUR, MLHK is a mid-cap company. Its Price-to-Earnings (P/E) ratio of 87.06 suggests that the stock may be overvalued relative to its earnings. However, the Return on Equity (RoE) of 23.67% indicates a strong ability to generate profits from shareholders equity. Key drivers of MLHKs financial performance include government defense spending, global security trends, and the companys product portfolio, which includes firearms and other defense-related equipment.
To further assess MLHKs investment potential, we should consider key performance indicators (KPIs) such as revenue growth, operating margin, and cash flow generation. Additionally, economic drivers like GDP growth, interest rates, and defense budgets in key markets (e.g., Europe, North America) can impact the companys financial performance. A thorough analysis of these factors can help identify potential opportunities and risks associated with investing in MLHK.
From a valuation perspective, MLHKs high P/E ratio and significant deviation from its 52-week high (171.91) and low (67.50) suggest that the stocks price may be subject to volatility. The current price of 67.50 is near the 52-week low, potentially indicating a buying opportunity or a sign of underlying issues. Further analysis is required to determine the cause of this price movement and its implications for future performance.
MLHK Stock Overview
| Market Cap in USD | 2,910m |
| Sub-Industry | Aerospace & Defense |
| IPO / Inception |
MLHK Stock Ratings
| Growth Rating | 26.1 |
| Fundamental | 77.2% |
| Dividend Rating | 15.7 |
| Rel. Strength | -59.3 |
| Analysts | - |
| Fair Price Momentum | 57.24 EUR |
| Fair Price DCF | 7.49 EUR |
MLHK Dividends
| Dividend Yield 12m | 0.13% |
| Yield on Cost 5y | 0.21% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 7.1% |
MLHK Growth Ratios
| Growth Correlation 3m | -93.6% |
| Growth Correlation 12m | 11.5% |
| Growth Correlation 5y | 81% |
| CAGR 5y | 3.77% |
| CAGR/Max DD 5y | 0.06 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | -36.86 |
| Beta | -0.360 |
| Volatility | 82.51% |
| Current Volume | 1.3k |
| Average Volume 20d | 1.3k |
| Stop Loss | 64.4 (-5.3%) |
| Signal | -0.25 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (30.3m TTM) > 0 and > 6% of Revenue (6% = 21.0m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 19.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.86% (prev 41.52%; Δ -4.66pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 88.6m > Net Income 30.3m (YES >=105%, WARN >=100%) |
| Net Debt (51.8m) to EBITDA (67.0m) ratio: 0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (35.6m) change vs 12m ago 0.40% (target <= -2.0% for YES) |
| Gross Margin 34.03% (prev 35.76%; Δ -1.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 87.38% (prev 84.09%; Δ 3.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.38 (EBITDA TTM 67.0m / Interest Expense TTM 6.28m) >= 6 (WARN >= 3) |
Altman Z'' 2.41
| (A) 0.29 = (Total Current Assets 272.1m - Total Current Liabilities 143.1m) / Total Assets 440.4m |
| (B) -0.11 = Retained Earnings (Balance) -47.7m / Total Assets 440.4m |
| (C) 0.13 = EBIT TTM 52.7m / Avg Total Assets 400.5m |
| (D) -0.04 = Book Value of Equity -12.2m / Total Liabilities 301.8m |
| Total Rating: 2.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.24
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 2.66% = 1.33 |
| 3. FCF Margin 19.22% = 4.81 |
| 4. Debt/Equity 0.66 = 2.29 |
| 5. Debt/Ebitda 1.37 = 1.19 |
| 6. ROIC - WACC 13.44% = 12.50 |
| 7. RoE 23.67% = 1.97 |
| 8. Rev. Trend 53.20% = 2.66 |
| 9. Rev. CAGR 1.26% = 0.16 |
| 10. EPS Trend data missing |
| 11. EPS CAGR -17.30% = -2.16 |
What is the price of MLHK shares?
Over the past week, the price has changed by -9.33%, over one month by -29.90%, over three months by -48.06% and over the past year by -41.32%.
Is H&K a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MLHK is around 57.24 EUR . This means that MLHK is currently overvalued and has a potential downside of -15.82%.
Is MLHK a buy, sell or hold?
What are the forecasts/targets for the MLHK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 61.6 | -9.5% |
MLHK Fundamental Data Overview
Market Cap EUR = 2.48b (2.48b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 44.3m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 80.0
P/S = 7.0986
P/B = 17.2806
Beta = 0.95
Revenue TTM = 350.0m EUR
EBIT TTM = 52.7m EUR
EBITDA TTM = 67.0m EUR
Long Term Debt = 80.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 11.3m EUR (from shortTermDebt, last quarter)
Debt = 91.8m EUR (Calculated: Short Term 11.3m + Long Term 80.5m)
Net Debt = 51.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.53b EUR (2.48b + Debt 91.8m - CCE 44.3m)
Interest Coverage Ratio = 8.38 (Ebit TTM 52.7m / Interest Expense TTM 6.28m)
FCF Yield = 2.66% (FCF TTM 67.3m / Enterprise Value 2.53b)
FCF Margin = 19.22% (FCF TTM 67.3m / Revenue TTM 350.0m)
Net Margin = 8.65% (Net Income TTM 30.3m / Revenue TTM 350.0m)
Gross Margin = 34.03% ((Revenue TTM 350.0m - Cost of Revenue TTM 230.9m) / Revenue TTM)
Tobins Q-Ratio = -207.5 (set to none) (Enterprise Value 2.53b / Book Value Of Equity -12.2m)
Interest Expense / Debt = 1.42% (Interest Expense 1.30m / Debt 91.8m)
Taxrate = 23.77% (from yearly Income Tax Expense: 9.81m / 41.3m)
NOPAT = 40.1m (EBIT 52.7m * (1 - 23.77%))
Current Ratio = 1.90 (Total Current Assets 272.1m / Total Current Liabilities 143.1m)
Debt / Equity = 0.66 (Debt 91.8m / last Quarter total Stockholder Equity 138.6m)
Debt / EBITDA = 1.37 (Net Debt 51.8m / EBITDA 67.0m)
Debt / FCF = 1.36 (Debt 91.8m / FCF TTM 67.3m)
Total Stockholder Equity = 127.9m (last 4 quarters mean)
RoA = 6.88% (Net Income 30.3m, Total Assets 440.4m )
RoE = 23.67% (Net Income TTM 30.3m / Total Stockholder Equity 127.9m)
RoCE = 25.27% (Ebit 52.7m / (Equity 127.9m + L.T.Debt 80.5m))
RoIC = 18.00% (NOPAT 40.1m / Invested Capital 223.0m)
WACC = 4.56% (E(2.48b)/V(2.58b) * Re(4.69%)) + (D(91.8m)/V(2.58b) * Rd(1.42%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 70.0 | Cagr: 5.07%
Discount Rate = 4.69% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 66.71% ; FCFE base≈67.3m ; Y1≈37.9m ; Y5≈12.8m
Fair Price DCF = 7.49 (DCF Value 265.8m / Shares Outstanding 35.5m; 5y FCF grow -50.0% → 3.0% )
Revenue Correlation: 53.20 | Revenue CAGR: 1.26%
Revenue Growth Correlation: 50.84%
EPS Correlation: N/A | EPS CAGR: -17.30%
EPS Growth Correlation: 22.53%